Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation”

4 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT02285062

What this trial is testing

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

Who this might be right for

Lymphoma, Large B-Cell, Diffuse

Testing effectiveness (Phase 2)Active Not RecruitingNCT05507541

What this trial is testing

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for

Recurrent ALK Positive Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+25 more

Early research (Phase 1)Study completedNCT02924402

What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for

B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia

Xencor, Inc. 154

Early research (Phase 1)Looking for participantsNCT06544265

What this trial is testing

SynKIR-310 for Relapsed/Refractory B-NHL

Who this might be right for

B Cell LymphomaNHL, AdultMantle Cell Lymphoma+21 more

Verismo Therapeutics 18